AMBI Skin Care Scholarship Winners
AMBI Skincare proudly announces the five winners of the AMBI Scholarship in Science & Medicine, a scholarship program designed to recognize, reward and support African American and Hispanic women in fields in which they are currently underrepresented.
“Science is the ‘DNA’ of the AMBI Skincare Brand and allows us to deliver clinically proven products infused with formulations that are specially designed to meet the skincare needs of women with melanin rich skin tones,” says Denna Singleton, AMBI Brand Product Director. “We are honored to support these extraordinary individuals and encourage more women to follow their dreams in the fields of science and medicine.”
This year’s winners set a positive example for African American and Hispanic women. The Scholarship winners each have a unique story that has motivated them to pursue a career in science or medicine. Chosen from a plethora of entries, the following women have been awarded $10,000 towards tuition for any science or medicine programs within the United States:
- Linda Adebisi of Bloomington, Indiana - Indiana University School of Optometry
- Toni Aluko of Burtonsville, Maryland- University of Maryland, College Park
- Tanya Anim of Daytona Beach, Florida - Florida State University School of Medicine
- Naima Bridges of San Francisco, California - University of California, San Francisco
- Amanda Ouzer of Brooklyn, New York - Temple University School of Dentistry
The AMBI Scholarship in Science & Medicine was inspired by its first recipient, Karen Morris-Priester. As the first grandmother to graduate Yale Medical School, the 44-year old Pennsylvania native’s story exemplified desire, drive and commitment to making a difference in her community as a physician. Her life has been one of personal sacrifice to reach this goal, and she was honored for her outstanding achievements by the AMBI Brand on “The Oprah Winfrey Show.”
See Also:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.
Comments
No comments yet.
Leave a comment